Extracellular matrix alterations, accelerated leukocyte infiltration and enhanced axonal sprouting after spinal cord hemisection in tenascin-C-deficient mice

Acta Histochemica

Volumn 115, Issue 8, 2013, Pages 865-878

  Schreiber, Jenny ^a   Schachner, Melitta ^a   Schumacher, Udo ^a   Lorke, Dietrich Ernst ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Astrocytes; Collagen; Fibronectin; Laminin; Microglia; Mouse; Neurofilament

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; TENASCIN; TENASCIN-N PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; GENOTYPE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MACROGLIA; MACROPHAGE; MICROGLIA; MOUSE; NERVE FIBER GROWTH; NERVE SPROUTING; NEUROFILAMENT; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN FUNCTION; SPINAL CORD HEMISECTION; WHITE MATTER; ANIMAL; C57BL MOUSE; CYTOLOGY; DEFICIENCY; EXTRACELLULAR MATRIX; KNOCKOUT MOUSE; METABOLISM; NERVE FIBER; PHYSIOLOGY; SPINAL CORD; SURGERY;

MAMMALIA; MUS;

ANIMALS; AXONS; EXTRACELLULAR MATRIX; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPINAL CORD; TENASCIN;

EID: 84887207056     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.04.009     Document Type: Article

References (112)

1. Ahmed I., Liu H.Y., Mamiya P.C., Ponery A.S., Babu A.N., Weik T., et al. Three-dimensional nanofibrillar surfaces covalently modified with tenascin-C-derived peptides enhance neuronal growth in vitro. J Biomed Mater Res A 2006, 76:851-860.
2. Andrews M.R., Czvitkovich S., Dassie E., Vogelaar C.F., Faissner A., Blits B., et al. Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci 2009, 29:5546-5557.
3. Bannister L.H., Gray H., Williams P.L. Cells and tissues. Gray's anatomy: the anatomical basis of medicine and surgery 1995, 17-90. Churchill Livingstone, New York/Edinburgh/London/Tokyo/Madrid/Melbourne. H. Gray, P.L. Williams, L.H. Bannister (Eds.).
4. Bartsch U. The extracellular matrix molecule tenascin-C: expression in vivo and functional characterization in vitro. Prog Neurobiol 1996, 49:145-168.
5. Brazda N., Muller H.W. Pharmacological modification of the extracellular matrix to promote regeneration of the injured brain and spinal cord. Prog Brain Res 2009, 175:269-281.
6. Bregman B.S., Coumans J.V., Dai H.N., Kuhn P.L., Lynskey J., McAtee M., et al. Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog Brain Res 2002, 137:257-273.
7. Brellier F., Tucker R.P., Chiquet-Ehrismann R. Tenascins and their implications in diseases and tissue mechanics. Scand J Med Sci Sports 2009, 19:511-519.
8. Burry R.W. Specificity controls for immunocytochemical methods. J Histochem Cytochem 2000, 48:163-166.
9. Burry R.W. Controls for immunocytochemistry: an update. J Histochem Cytochem 2011, 59:6-12.
10. Busch S.A., Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol 2007, 17:120-127.
11. Chen J., Joon Lee H., Jakovcevski I., Shah R., Bhagat N., Loers G., et al. The extracellular matrix glycoprotein tenascin-C is beneficial for spinal cord regeneration. Mol Ther 2010, 18:1769-1777.
12. Chilosi M., Lestani M., Benedetti A., Montagna L., Pedron S., Scarpa A., et al. Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues. Am J Pathol 1993, 143:1348-1355.
13. Clark R.A., Erickson H.P., Springer T.A. Tenascin supports lymphocyte rolling. J Cell Biol 1997, 137:755-765.
14. Clark R.A.F. The molecular and cellular biology of wound repair 1996, Plenum Press, New York. 2nd ed.
15. Costa S., Planchenault T., Charriere-Bertrand C., Mouchel Y., Fages C., Juliano S., et al. Astroglial permissivity for neuritic outgrowth in neuron-astrocyte cocultures depends on regulation of laminin bioavailability. Glia 2002, 37:105-113.
16. Cybulska-Klosowicz A., Zakrzewska R., Pyza E., Kossut M., Schachner M. Reduced plasticity of cortical whisker representation in adult tenascin-C-deficient mice after vibrissectomy. Eur J Neurosci 2004, 20:1538-1544.
17. Davidoff M., Schulze W. Combination of the peroxidase anti-peroxidase (PAP)- and avidin-biotin-peroxidase complex (ABC)-techniques: an amplification alternative in immunocytochemical staining. Histochemistry 1990, 93:531-536.
18. de Chevigny A., Lemasson M., Saghatelyan A., Sibbe M., Schachner M., Lledo P.M. Delayed onset of odor detection in neonatal mice lacking tenascin-C. Mol Cell Neurosci 2006, 32:174-186.
19. Deckner M., Lindholm T., Cullheim S., Risling M. Differential expression of tenascin-C, tenascin-R, tenascin/J1, and tenascin-X in spinal cord scar tissue and in the olfactory system. Exp Neurol 2000, 166:350-362.
20. Dityatev A., Seidenbecher C.I., Schachner M. Compartmentalization from the outside: the extracellular matrix and functional microdomains in the brain. Trends Neurosci 2010, 33:503-512.
21. Dobbertin A., Czvitkovich S., Theocharidis U., Garwood J., Andrews M.R., Properzi F., et al. Analysis of combinatorial variability reveals selective accumulation of the fibronectin type III domains B and D of tenascin-C in injured brain. Exp Neurol 2010, 225:60-73.
22. Dorries U., Taylor J., Xiao Z., Lochter A., Montag D., Schachner M. Distinct effects of recombinant tenascin-C domains on neuronal cell adhesion, growth cone guidance, and neuronal polarity. J Neurosci Res 1996, 43:420-438.
23. El-Karef A., Yoshida T., Gabazza E.C., Nishioka T., Inada H., Sakakura T., et al. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol 2007, 211:86-94.
24. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007, 127:514-525.
25. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25:1439-1451.
26. 2+ channel-dependent forms of hippocampal synaptic plasticity in mice deficient in the extracellular matrix glycoprotein tenascin-C. J Neurosci 2002, 22:7177-7194.
27. Faissner A. The tenascin gene family in axon growth and guidance. Cell Tissue Res 1997, 290:331-341.
28. Faissner A., Kruse J. J1/tenascin is a repulsive substrate for central nervous system neurons. Neuron 1990, 5:627-637.
29. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res Bull 1999, 49:377-391.
30. Fawcett J.W., Fersht N., Housden L., Schachner M., Pesheva P. Axonal growth on astrocytes is not inhibited by oligodendrocytes. J Cell Sci 1992, 103(Pt 2):571-579.
31. Fitch M.T., Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp Neurol 1997, 148:587-603.
32. Forsberg E., Hirsch E., Frohlich L., Meyer M., Ekblom P., Aszodi A., et al. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci USA 1996, 93:6594-6599.
33. Garcion E., Faissner A., ffrench-Constant C. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 2001, 128:2485-2496.
34. Garwood J., Theocharidis U., Calco V., Dobbertin A., Faissner A. Existence of tenascin-C isoforms in rat that contain the alternatively spliced AD1 domain are developmentally regulated during hippocampal development. Cell Mol Neurobiol 2012, 32:279-287.
35. Gotz B., Scholze A., Clement A., Joester A., Schutte K., Wigger F., et al. Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J Cell Biol 1996, 132:681-699.
36. Grierson J.P., Petroski R.E., Ling D.S., Geller H.M. Astrocyte topography and tenascin cytotactin expression: correlation with the ability to support neuritic outgrowth. Brain Res Dev Brain Res 1990, 55:11-19.
37. Grimpe B., Silver J. The extracellular matrix in axon regeneration. Prog Brain Res 2002, 137:333-349.
38. Gundersen D., Tran-Thang C., Sordat B., Mourali F., Ruegg C. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J Immunol 1997, 158:1051-1060.
39. Guntinas-Lichius O., Angelov D.N., Morellini F., Lenzen M., Skouras E., Schachner M., et al. Opposite impacts of tenascin-C and tenascin-R deficiency in mice on the functional outcome of facial nerve repair. Eur J Neurosci 2005, 22:2171-2179.
40. Hashimoto M., Koda M., Ino H., Yoshinaga K., Murata A., Yamazaki M., et al. Gene expression profiling of cathepsin D, metallothioneins-1 and -2, osteopontin, and tenascin-C in a mouse spinal cord injury model by cDNA microarray analysis. Acta Neuropathol 2005, 109:165-180.
41. Hauzenberger D., Klominek J., Bergstrom S.E., Sundqvist K.G. T lymphocyte migration: the influence of interactions via adhesion molecules, the T cell receptor, and cytokines. Crit Rev Immunol 1995, 15:285-316.
42. Hauzenberger D., Olivier P., Gundersen D., Ruegg C. Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin. Eur J Immunol 1999, 29:1435-1447.
43. Hermanns S., Klapka N., Muller H.W. The collagenous lesion scar - an obstacle for axonal regeneration in brain and spinal cord injury. Restor Neurol Neurosci 2001, 19:139-148.
44. Hibino S., Kato K., Kudoh S., Yagita H., Okumura K. Tenascin suppresses CD3-mediated T cell activation. Biochem Biophys Res Commun 1998, 250:119-124.
45. Holley J.E., Gveric D., Whatmore J.L., Gutowski N.J. Tenascin C induces a quiescent phenotype in cultured adult human astrocytes. Glia 2005, 52:53-58.
46. Holmseth S., Zhou Y., Follin-Arbelet V.V., Lehre K.P., Bergles D.E., Danbolt N.C. Specificity controls for immunocytochemistry: the antigen preadsorption test can lead to inaccurate assessment of antibody specificity. J Histochem Cytochem 2012, 60:174-187.
47. Huang J.Y., Cheng Y.J., Lin Y.P., Lin H.C., Su C.C., Juliano R., et al. Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression. J Immunol 2010, 185:1450-1459.
48. Inman D.M., Steward O. Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice. J Comp Neurol 2003, 462:431-449.
49. Irintchev A., Rollenhagen A., Troncoso E., Kiss J.Z., Schachner M. Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb Cortex 2005, 15:950-962.
50. Jones F.S., Jones P.L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 2000, 218:235-259.
51. Karus M., Denecke B., ffrench-Constant C., Wiese S., Faissner A. The extracellular matrix molecule tenascin C modulates expression levels and territories of key patterning genes during spinal cord astrocyte specification. Development 2011, 138:5321-5331.
52. Klapka N., Muller H.W. Collagen matrix in spinal cord injury. J Neurotrauma 2006, 23:422-435.
53. Koyama Y., Kusubata M., Yoshiki A., Hiraiwa N., Ohashi T., Irie S., et al. Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. J Invest Dermatol 1998, 111:930-935.
54. Kros J.M., Waarsenburg N., Hayes D.P., Hop W.C., van Dekken H. Cytogenetic analysis of gemistocytic cells in gliomas. J Neuropathol Exp Neurol 2000, 59:679-686.
55. Kuznetsova S.A., Roberts D.D. Functional regulation of T lymphocytes by modulatory extracellular matrix proteins. Int J Biochem Cell Biol 2004, 36:1126-1134.
56. Lazarovits A.I., Karsh J. Differential expression in rheumatoid synovium and synovial fluid of alpha 4 beta 7 integrin. A novel receptor for fibronectin and vascular cell adhesion molecule-1. J Immunol 1993, 151:6482-6489.
57. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689.
58. Liesi P. Extracellular matrix and neuronal movement. Experientia 1990, 46:900-907.
59. Liesi P., Kauppila T. Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar. Exp Neurol 2002, 173:31-45.
60. Liu H.Y., Nur E.K.A., Schachner M., Meiners S. Neurite guidance by the FnC repeat of human tenascin-C: neurite attraction vs. neurite retention. Eur J Neurosci 2005, 22:1863-1872.
61. Lochter A., Schachner M. Tenascin and extracellular matrix glycoproteins: from promotion to polarization of neurite growth in vitro. J Neurosci 1993, 13:3986-4000.
62. Lochter A., Vaughan L., Kaplony A., Prochiantz A., Schachner M., Faissner A. J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J Cell Biol 1991, 113:1159-1171.
63. Loike J.D., Cao L., Budhu S., Hoffman S., Silverstein S.C. Blockade of alpha 5 beta 1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimensional gels of extracellular matrix proteins. J Immunol 2001, 166:7534-7542.
64. Lorke D., Moller P. The early appearance of fibronectin in the course of metastatic tumor growth in lymph nodes. J Cancer Res Clin Oncol 1985, 109:65-71.
65. Mackie E.J. Molecules in focus: tenascin-C. Int J Biochem Cell Biol 1997, 29:1133-1137.
66. Mackie E.J., Halfter W., Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988, 107:2757-2767.
67. Mackie E.J., Tucker R.P. The tenascin-C knockout revisited. J Cell Sci 1999, 112(Pt 22):3847-3853.
68. Maseruka H., Bonshek R.E., Tullo A.B. Tenascin-C expression in normal, inflamed, and scarred human corneas. Br J Ophthalmol 1997, 81:677-682.
69. Matsuda A., Yoshiki A., Tagawa Y., Matsuda H., Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci 1999, 40:1071-1080.
70. McTigue D.M., Popovich P.G., Jakeman L.B., Stokes B.T. Strategies for spinal cord injury repair. Prog Brain Res 2000, 128:3-8.
71. Meiners S., Mercado M.L., Geller H.M. The multi-domain structure of extracellular matrix molecules: implications for nervous system regeneration. Prog Brain Res 2000, 128:23-31.
72. Meiners S., Mercado M.L., Nur-e-Kamal M.S., Geller H.M. Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance. J Neurosci 1999, 19:8443-8453.
73. Meiners S., Powell E.M., Geller H.M. A distinct subset of tenascin/CS-6-PG-rich astrocytes restricts neuronal growth in vitro. J Neurosci 1995, 15:8096-8108.
74. Midwood K.S., Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 2009, 3:287-310.
75. Morellini F., Schachner M. Enhanced novelty-induced activity, reduced anxiety, delayed resynchronization to daylight reversal and weaker muscle strength in tenascin-C-deficient mice. Eur J Neurosci 2006, 23:1255-1268.
76. Nakao N., Hiraiwa N., Yoshiki A., Ike F., Kusakabe M. Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am J Pathol 1998, 152:1237-1245.
77. Onose G., Anghelescu A., Muresanu D.F., Padure L., Haras M.A., Chendreanu C.O., et al. A review of published reports on neuroprotection in spinal cord injury. Spinal Cord 2009, 47:716-726.
78. Pesheva P., Probstmeier R., Skubitz A.P., McCarthy J.B., Furcht L.T., Schachner M. Tenascin-R (J1 160/180) inhibits fibronectin-mediated cell adhesion - functional relatedness to tenascin-C. J Cell Sci 1994, 107:2323-2333.
79. Pires Neto M.A., Braga-de-Souza S., Lent R. Extracellular matrix molecules play diverse roles in the growth and guidance of central nervous system axons. Braz J Med Biol Res 1999, 32:633-638.
80. Pradidarcheep W., Labruyere W.T., Dabhoiwala N.F., Lamers W.H. Lack of specificity of commercially available antisera: better specifications needed. J Histochem Cytochem 2008, 56:1099-1111.
81. Priestley J.V., Ramer M.S., King V.R., McMahon S.B., Brown R.A. Stimulating regeneration in the damaged spinal cord. J Physiol Paris 2002, 96:123-133.
82. Puente Navazo M.D., Valmori D., Ruegg C. The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production. J Immunol 2001, 167:6431-6440.
83. Reier P.J., Houle J.D. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv Neurol 1988, 47:87-138.
84. Rigato F., Garwood J., Calco V., Heck N., Faivre-Sarrailh C., Faissner A. Tenascin-C promotes neurite outgrowth of embryonic hippocampal neurons through the alternatively spliced fibronectin type III BD domains via activation of the cell adhesion molecule F3/contactin. J Neurosci 2002, 22:6596-6609.
85. Ruegg C.R., Chiquet-Ehrismann R., Alkan S.S. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 1989, 86:7437-7441.
86. Saga Y., Yagi T., Ikawa Y., Sakakura T., Aizawa S. Mice develop normally without tenascin. Genes Dev 1992, 6:1821-1831.
87. Sandvig A., Berry M., Barrett L.B., Butt A., Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004, 46:225-251.
88. Semple-Rowland S.L., Mahatme A., Popovich P.G., Green D.A., Hassler G., Stokes B.T., et al. Analysis of TGF-beta 1 gene expression in contused rat spinal cord using quantitative RT-PCR. J Neurotrauma 1995, 12:1003-1014.
89. Shimizu Y., Shaw S. Lymphocyte interactions with extracellular matrix. FASEB J 1991, 5:2292-2299.
90. Sirko S., Akita K., Von Holst A., Faissner A. Structural and functional analysis of chondroitin sulfate proteoglycans in the neural stem cell niche. Methods Enzymol 2010, 479:37-71.
91. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 2005, 11:400-407.
92. Sosale A., Robson J.A., Stelzner D.J. Laminin distribution during corticospinal tract development and after spinal cord injury. Exp Neurol 1988, 102:14-22.
93. Sta Iglesia D.D., Gala P.H., Qiu T., Stepp M.A. Integrin expression during epithelial migration and restratification in the tenascin-C-deficient mouse cornea. J Histochem Cytochem 2000, 48:363-376.
94. Steindler D.A. Glial boundaries in the developing nervous system. Annu Rev Neurosci 1993, 16:445-470.
95. Steindler D.A., Settles D., Erickson H.P., Laywell E.D., Yoshiki A., Faissner A., et al. Tenascin knockout mice: barrels, boundary molecules, and glial scars. J Neurosci 1995, 15:1971-1983.
96. Stichel C.C., Hermanns S., Luhmann H.J., Lausberg F., Niermann H., D'Urso D., et al. Inhibition of collagen IV deposition promotes regeneration of injured CNS axons. Eur J Neurosci 1999, 11:632-646.
97. Stichel C.C., Niermann H., D'Urso D., Lausberg F., Hermanns S., Muller H.W. Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons. Neuroscience 1999, 93:321-333.
98. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog Neurobiol 1999, 57:563-581.
99. Strekalova T., Sun M., Sibbe M., Evers M., Dityatev A., Gass P., et al. Fibronectin domains of extracellular matrix molecule tenascin-C modulate hippocampal learning and synaptic plasticity. Mol Cell Neurosci 2002, 21:173-187.
100. Sumioka T., Fujita N., Kitano A., Okada Y., Saika S. Impaired angiogenic response in the cornea of mice lacking tenascin C. Invest Ophthalmol Vis Sci 2011, 52:2462-2467.
101. Sundqvist K.G., Strom H., Arencibia I., Hauzenberger D. Fibronectin and lymphocytes in inflammatory tissue. Studies of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other inflammatory arthritides. Cell Adhes Commun 1994, 2:239-247.
102. Talts J.F., Wirl G., Dictor M., Muller W.J., Fassler R. Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. J Cell Sci 1999, 112(Pt 12):1855-1864.
103. Tang X., Davies J.E., Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 2003, 71:427-444.
104. Tate M.C., Shear D.A., Hoffman S.W., Stein D.G., Archer D.R., LaPlaca M.C. Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplant 2002, 11:283-295.
105. Taylor J., Pesheva P., Schachner M. Influence of janusin and tenascin on growth cone behavior in vitro. J Neurosci Res 1993, 35:347-362.
106. Treloar H.B., Ray A., Dinglasan L.A., Schachner M., Greer C.A. Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb. J Neurosci 2009, 29:9405-9416.
107. Uematsu J., Ono K., Yamano T., Shimada M. Development of corticospinal tract fibers and their plasticity I: quantitative analysis of the developing corticospinal tract in mice. Brain Dev 1996, 18:29-34.
108. von Holst A. Tenascin C in stem cell niches: redundant, permissive or instructive?. Cells Tissues Organs 2008, 188:170-177.
109. Wehrle B., Chiquet M. Tenascin is accumulated along developing peripheral nerves and allows neurite outgrowth in vitro. Development 1990, 110:401-415.
110. Wiese S., Karus M., Faissner A. Astrocytes as a source for extracellular matrix molecules and cytokines. Front Pharmacol 2012, 3:120.
111. Yu Y.M., Cristofanilli M., Valiveti A., Ma L., Yoo M., Morellini F., et al. The extracellular matrix glycoprotein tenascin-C promotes locomotor recovery after spinal cord injury in adult zebrafish. Neuroscience 2011, 183:238-250.
112. Zhang Y., Winterbottom J.K., Schachner M., Lieberman A.R., Anderson P.N. Tenascin-C expression and axonal sprouting following injury to the spinal dorsal columns in the adult rat. J Neurosci Res 1997, 49:433-450.